DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Addeo R, Caraglia M, Iuliano G.
Pembrolizumab: the value of PDL1 biomarker in head and neck cancer.
Expert Opin Biol Ther 2016;
16: 1075-1078
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.